FDA approves Bayer's Stivarga to treat most common liver cancer

Thursday, May 18 The U.S. Food and Drug Administration said on Thursday it has approved Bayer AG's drug Stivarga to treat liver cancer, the first such approval in nearly a decade.

Source: http://www.reuters.com/article/us-bayer-cancer-liver-idUSKBN17T2PU

Comments

POSTED:2016-07-20 19:58:04

AUTHOR: sllishay ken



POSTED:2017-07-04 15:04:11

AUTHOR: Timothy L Fortin

2nd line treatment soon to be over taken by immunotherapy in my opinion


About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.